Clinical Trial Update: Continuous Infusion of Terlipressin in Septic Shock [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating continuous infusion of terlipressin for septic shock has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Septic Shock

Drugs mentioned

• Terlipressin (terlipressin)

Snippet

Sponsor: University of Roma La Sapienza | Conditions: Septic Shock | Phase 2 | Status: COMPLETED